Načítá se...
Commment on the review entitled “A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer” by Chiva LM and Gonzalez-Martin A.
• We raised some methodological concerns and made some comments on the systematic review by Chiva and colleague. • To state that Cytoreduction & HIPEC is not beneficial in front line and platinum sensitive recurrence is highly disputable. • Anyway, the combined treatment should be offered in the...
Uloženo v:
| Vydáno v: | Gynecol Oncol Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750010/ https://ncbi.nlm.nih.gov/pubmed/26937478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2015.11.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|